Mollie Shields-Uehling

Mollie Shields-Uehling is president and CEO of SAFE-BioPharma Association


Identity Trust is a Must in Clinical Development Collaborations

May 24, 2016

Identity trust platforms assure clinical investigators that their credentials are legitimate by allowing use of a single identity that can be recognized across multiple entities. These platforms support collaboration by allowing drug development participants to access data, sign and exchange documents.